4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-20-012541
Options or other derivatives
- Director acquired 40,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FARRELL STEPHEN C Director | 2020-07-01 | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | D: show line 1 in the form |
Loading xslF345X03/ownership.xml…